Vidasym Overview
- Year Founded
-
2009
- Status
-
Private
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$1.48M
- Investors
-
4
Vidasym General Information
Description
Operator of a clinical-stage company intended to cure chronic kidney disease. The company is developing small molecule drugs primarily for renal disorders, providing patients to get relief from diseases.
Contact Information
Website
www.vidasym.comCorporate Office
- 2201 West Campbell Park Drive
- Suite 13
- Chicago, IL 60612
- United States
Corporate Office
- 2201 West Campbell Park Drive
- Suite 13
- Chicago, IL 60612
- United States
Vidasym Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Grant | 01-Apr-2016 | $1.48M | Completed | Clinical Trials - General | ||
5. Grant | 11-May-2015 | Completed | Clinical Trials - General | |||
4. Grant | 31-Aug-2014 | Completed | Clinical Trials - General | |||
3. Grant | 31-Aug-2013 | Completed | Startup | |||
2. Angel (individual) | $2.5M | $2.5M | Completed | Startup | ||
1. Angel (individual) | Completed | Startup |
Vidasym Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
National Institutes of Arthritis and Musculoskeletal Diseases | Other | |||
U.S. Department of Health and Human Services | Government | |||
Alan Lau | Angel (individual) | Minority | ||
National Institutes of Health | Government |
Vidasym FAQs
-
When was Vidasym founded?
Vidasym was founded in 2009.
-
Where is Vidasym headquartered?
Vidasym is headquartered in Chicago, IL.
-
What industry is Vidasym in?
Vidasym’s primary industry is Drug Discovery.
-
Is Vidasym a private or public company?
Vidasym is a Private company.
-
What is Vidasym’s current revenue?
The current revenue for Vidasym is
. -
How much funding has Vidasym raised over time?
Vidasym has raised $2.5M.
-
Who are Vidasym’s investors?
National Institutes of Arthritis and Musculoskeletal Diseases, U.S. Department of Health and Human Services, Alan Lau, and National Institutes of Health have invested in Vidasym.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »